Full Breakdown
Corporate Sponsorship and Government Access at the RFK Jr.-Linked MAHA Summit
By Drooid · · How we work
Core Event
A nonprofit tied to U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. arranged the MAHA Summit, where corporate sponsors can pay for direct access to senior federal health officials. The top sponsorship tier, $300,000, promises a speaking slot, influence over panel topics, and a private dinner for 30 guests with Kennedy and CMS administrator Mehmet Oz. The summit is slated for late September in Washington, D.C.
Background & Context
The event is organized by the MAHA Center, run by Tony Lyons, Kennedy’s longtime publisher. The MAHA Center is part of the “Make America Healthy Again” movement, which claims to oppose corporate capture while accepting corporate sponsorships. Its political arm, the MAHA PAC, has raised most of its funds from a small number of donors linked to the drug industry.
Data & Statistics
- Sponsorship tiers range from $20,000 to $300,000.
- The MAHA Action subscription costs $6,000 per year and includes four DC events and a signed copy of Kennedy’s book.
- The MAHA PAC pledged $100 million but has spent less than $800,000, mainly on a campaign against a Republican critic of Kennedy.
- Corporate sponsors include Walmart, OpenAI, UnitedHealth, Elevance Health, Compass Pathways, Definium Therapeutics, Helus Pharma, ResMed, Grail, and several peptide startups.
Official Statements & Responses
Emily Hilliard, senior press secretary for HHS, said department officials listed as speakers were not involved in planning or sponsorship negotiations and were unaware of the arrangements. Participating companies issued statements emphasizing their desire to engage with policymakers on mental-health reform, AI in health care, and disease prevention.
Criticism & Opposition
Ethics watchdog Donald Sherman, president of Citizens for Responsibility and Ethics in Washington, argued the arrangement raises propriety questions, noting that knowledge of the sponsorship eliminates plausible deniability. Former White House ethics lawyer Richard Painter said the executive branch must vet speaking requests to prevent officials’ names from being used for fundraising. MAHA supporter Scarlett Fang called the summit “complete corporate capture,” and an anonymous grassroots organizer expressed anger that health-insurer representatives were present.
Why It Matters
The summit highlights a tension between the MAHA movement’s anti-corporate rhetoric and its reliance on corporate funding. Paid access to senior HHS officials could create real or perceived conflicts of interest, especially as many sponsors are regulated by those agencies. The presence of AI firms, insurers, and psychedelic-drug developers signals an industry push to shape upcoming regulatory discussions.
Conflicting Reports & Gaps
- Exact contribution amounts from each sponsor remain undisclosed; only a few logos appear on the event website.
- HHS officials claim no involvement in negotiations, but internal communications suggest some awareness.
- The MAHA PAC’s financial disclosures show a large fundraising promise but minimal spending, leaving its electoral influence unclear.
What’s Next
The summit will feature panels on AI in health care, disease prevention, and FDA modernization, with speakers such as HHS nominee Chris Klomp, FDA acting commissioner Kyle Diamantas, NIH director Jay Bhattacharya, and CMS administrator Mehmet Oz. Watchdog groups say they may seek further clarification on the ethics of paid access to federal officials.